Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetics a factor in PSA levels

16.07.2003


Genetics causes some men to test higher on the blood test for prostate cancer – even when they don’t have the disease – report researchers from Wake Forest University Baptist Medical Center and colleagues in the July 16 issue of the Journal of the National Cancer Institute.

The discovery could lead to more accurate testing and fewer unnecessary biopsies, said Scott D. Cramer, Ph.D., lead researcher, from Wake Forest.

"Up to 20 percent of men may have genetic variants that cause levels of prostate specific antigen (PSA) that are about 30 percent higher than other men, which could result in needless biopsies," said Cramer. The research was in collaboration with St. Louis University and Washington University School of Medicine.



The PSA blood test, which measures a protein made by prostatic cells, is the most widely used marker to screen for prostate cancer. Cramer, an assistant professor of cancer biology, said the new findings potentially could lead to changes in how PSA results are interpreted and which men are referred for biopsies.

"Further research will be needed to determine how this genetic marker can contribute to making PSA a more accurate screening tool," said Cramer. "Because of the huge importance of accurately diagnosing prostate cancer, we need to find the best way to use PSA to determine who has prostate cancer and who doesn’t."

The researchers analyzed blood samples from 405 white males, with a mean age of 63.7 years, who were part of a study looking at asbestos exposure. The researchers excluded men with prostate cancer. Using DNA sequencing, the researchers identified three variations in part of the gene that controls PSA levels. They found that the variations together contributed to a 30 percent increase in PSA levels. Their analysis suggests that if a man has one variation, he has all three. Approximately 20 percent of the study subjects had the variants.

Testing for the variants is quick and inexpensive, said Cramer, and could one day become part of the PSA screening process.

"If a man has the genetic variants, for example, perhaps he would have a higher PSA cutoff before a biopsy is recommended," said Cramer.

Cramer said additional research should focus on black men, who are known to have higher PSA levels and a greater risk for developing prostate cancer than white men, to see if they have the same variants as the study group.

In addition to race, other factors known to influence PSA levels include age and the presence of non-cancerous prostate disease. The research by Cramer and colleagues is the first to identify specific genetic variants that are responsible for genetic differences in PSA levels. "We’ve known that age, race and disease can influence PSA levels," said Cramer. "Now, we can add genetics to the list."

Currently, many physicians recommend biopsies when PSA levels are greater than 4 nanograms per milliliter (ng/ ml). However, there is considerable controversy about cutoffs, said Cramer.

In the study, which excluded men with prostate cancer, PSA levels ranged from .2 to 20 ng/ml. The group of men with the genetic variants that raised PSA had mean levels of 2.0 ng/ml. The other men had mean levels of 1.5 ng/mg. Cramer is conducting additional research to learn if the genetic variants may contribute to prostate cancer development.

"PSA has a biological role in the prostate – to digest proteins," said Cramer. "It has been shown that PSA can process proteins that are important for prostate growth. One hypothesis is that the higher PSA levels caused by the genetic variants may contribute to prostate cancer development, which would make testing for the variant even more important in the screening process."

Prostate cancer is the most common type of cancer found in American men, other than skin cancer, and is the second-leading cause of cancer death in men, exceeded only by lung cancer.

Karen Richardson | EurekAlert!
Further information:
http://www.wfubmc.edu

More articles from Health and Medicine:

nachricht Custom-tailored strategy against glioblastomas
26.09.2016 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New leukemia treatment offers hope
23.09.2016 | King Abdullah University of Science and Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New welding process joins dissimilar sheets better

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of light metals.
Scientists at the University of Stuttgart have now developed two new process variants that will considerably expand the areas of application for friction stir welding.
Technologie-Lizenz-Büro (TLB) GmbH supports the University of Stuttgart in patenting and marketing its innovations.

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of...

Im Focus: First quantum photonic circuit with electrically driven light source

Optical quantum computers can revolutionize computer technology. A team of researchers led by scientists from Münster University and KIT now succeeded in putting a quantum optical experimental set-up onto a chip. In doing so, they have met one of the requirements for making it possible to use photonic circuits for optical quantum computers.

Optical quantum computers are what people are pinning their hopes on for tomorrow’s computer technology – whether for tap-proof data encryption, ultrafast...

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

Im Focus: Complex hardmetal tools out of the 3D printer

For the first time, Fraunhofer IKTS shows additively manufactured hardmetal tools at WorldPM 2016 in Hamburg. Mechanical, chemical as well as a high heat resistance and extreme hardness are required from tools that are used in mechanical and automotive engineering or in plastics and building materials industry. Researchers at the Fraunhofer Institute for Ceramic Technologies and Systems IKTS in Dresden managed the production of complex hardmetal tools via 3D printing in a quality that are in no way inferior to conventionally produced high-performance tools.

Fraunhofer IKTS counts decades of proven expertise in the development of hardmetals. To date, reliable cutting, drilling, pressing and stamping tools made of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

European Health Forum Gastein 2016 kicks off today

28.09.2016 | Event News

Laser use for neurosurgery and biofabrication - LaserForum 2016 focuses on medical technology

27.09.2016 | Event News

Experts from industry and academia discuss the future mobile telecommunications standard 5G

23.09.2016 | Event News

 
Latest News

New imaging technique in Alzheimer’s disease - opens up possibilities for new drug development

28.09.2016 | Medical Engineering

Innovate coating extends the life of materials for industrial use

28.09.2016 | Materials Sciences

Blockchain Set to Transform the Financial Services Market

28.09.2016 | Business and Finance

VideoLinks
B2B-VideoLinks
More VideoLinks >>>